Video

SK pharmteco Capacity Update April 2025: Small Molecule

Source: SK pharmteco

SK pharmteco is a leading CDMO specializing in the development and manufacturing of small molecules, cell and gene therapies, and analytical testing. In this session, we will focus on our small molecule API solutions from clinical to commercial scale.

Join Nicholas Duda, Executive Director of Business Development, as he highlights our available capacity across North America, Europe, and Asia, and our unique capabilities:

  • Chromatography - Batch & Simulated Moving Bed (SMB)
  • Continuous Flow Processing
  • High Potency
  • Energetic Chemistry
  • Catalyst Development
  • Crystallization, Milling, & Characterization

Discover how our global sites, expertise, and customer-centric approach ensure supply chain security, regulatory compliance, and seamless project execution for your small molecule programs.

access the Video!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Outsourced Pharma

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)

SK pharmteco